Analysis variable
|
Full cohort (n=890,394)
|
25% (n=225,000)
|
10% (n=90,000)
|
5% (n=45,000)
|
1% (n=9,000)
|
REMR (n=890,394)
|
---|
Non-Hispanic White: % (n)
|
62
|
(547,645)
|
61
|
(138,470)
|
62
|
(55,489)
|
62
|
(27,853)
|
62
|
(5,529)
|
62
|
(547,645)
|
Non-Hispanic Black: % (n)
|
12
|
(107,935)
|
12
|
(27,317)
|
12
|
(10,941)
|
12
|
(5,406)
|
12
|
(1,097)
|
12
|
(107,935)
|
Hispanic: % (n)
|
14
|
(123,558)
|
14
|
(31,062)
|
14
|
(12,481)
|
14
|
(6,148)
|
14
|
(1,285)
|
13
|
(123,558)
|
Other: % (n)
|
12
|
(111,256)
|
13
|
(28,151)
|
12
|
(11,089)
|
12
|
(5,593)
|
12
|
(1,089)
|
13
|
(111,256)
|
Male: % (n)
|
98
|
(869,508)
|
98
|
(219,708)
|
98
|
(87,921)
|
98
|
(43,947)
|
98
|
(8,794)
|
98
|
(869,508)
|
Married: % (n)
|
65
|
(574,307)
|
64
|
(145,060)
|
65
|
(58,222)
|
64
|
(29,002)
|
65
|
(5,853)
|
64
|
(574,307)
|
Disability (mean % & sd)
|
12
|
(0.03)
|
12
|
(0.06)
|
12
|
(0.09)
|
12
|
(0.13)
|
13
|
(0.30)
|
12
|
(0.63)
|
Northeast
|
12
|
(103,056)
|
12
|
(25,994)
|
11
|
(10,274)
|
12
|
(5,272)
|
12
|
(1,074)
|
-
|
(103,056)
|
Mid-Atlantic
|
23
|
(201,058)
|
22
|
(50,579)
|
23
|
(20,328)
|
23
|
(10,230)
|
23
|
(2,000)
|
-
|
(201,058)
|
Midwest
|
21
|
(184,348)
|
21
|
(46,940)
|
21
|
(18,658)
|
21
|
(9,368)
|
20
|
(1,827)
|
-
|
(184,348)
|
South
|
30
|
(265,450)
|
30
|
(66,988)
|
30
|
(26,759)
|
29
|
(13,189)
|
30
|
(2,707)
|
-
|
(265,450)
|
West
|
15
|
(136,482)
|
15
|
(34,499)
|
16
|
(13,981)
|
15
|
(6,941)
|
16
|
(1,392)
|
-
|
(136,482)
|
Urban Residence
|
62
|
(548,786)
|
61
|
(138,339)
|
61
|
(55,324)
|
62
|
(27,701)
|
61
|
(5,513)
|
61
|
(548,786)
|
Rural Residence
|
38
|
(341,608)
|
39
|
(85,612)
|
39
|
(34,676)
|
38
|
(17,299)
|
39
|
(3,487)
|
39
|
(341,608)
|
Mean HbA1c (mean % & sd)
|
7.4
|
(0.002)
|
7.4
|
(0.003)
|
7.4
|
(0.005)
|
7.4
|
(0.007)
|
7.4
|
(0.016)
|
7.5
|
(0.030)
|
Mean HbA1c<8%: % (n)
|
73
|
(703,596)
|
73
|
(177,751)
|
73
|
(71,195)
|
73
|
(34,498)
|
71
|
(7,112)
|
70
|
(703,596)
|
No Comorbidities
|
57
|
(507,320)
|
57
|
(128,326)
|
57
|
(51,178)
|
57
|
(25,506)
|
57
|
(5,143)
|
57
|
(507,320)
|
1 Comorbidity
|
28
|
(248,898)
|
28
|
(62,961)
|
28
|
(25,309)
|
28
|
(12,655)
|
27
|
(2,456)
|
28
|
(248,898)
|
2 Comorbidities
|
11
|
(95,542)
|
11
|
(23,998)
|
11
|
(9,706)
|
11
|
(4,898)
|
11
|
(1,022)
|
11
|
(95,542)
|
3+ Comorbidities
|
4
|
(38,634)
|
4
|
(9,715)
|
4
|
(3,807)
|
4
|
(1,941)
|
4
|
(379)
|
4
|
(38,634)
|
- Not applicable due to sampling by VISN or aggregation by VISN.